MECHANISM OF ACTION OF SPARFLOXACIN AGAINST AND MECHANISM OF RESISTANCE IN GRAM-NEGATIVE AND GRAM-POSITIVE BACTERIA

被引:28
作者
PIDDOCK, LJV
ZHU, M
机构
[1] Antimicrobial Agents Res. Grp., Medical School, University of Birmingham, Birmingham
关键词
D O I
10.1128/AAC.35.11.2423
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The inhibition of DNA synthesis by sparfloxacin; accumulation of sparfloxacin into members of the family Enterobacteriaceae, Pseudomonas aeruginosa, and staphylococci; induction of recA in Escherichia coli; and the optimum bactericidal concentration (OBC) were measured, and killing kinetics at the OBC were estimated. The OBC and maximum recA-inducing concentration in E. coli were both 1-mu-g of sparfloxacin per ml. Accumulation was rapid; two- to threefold more sparfloxacin than ciprofloxacin accumulated in staphylococci and more sparfloxacin accumulated in staphylococci than in gram-negative bacteria. Laboratory mutants with decreased susceptibilities to quinolones alone or multiply resistant were selected from the Enterobacteriaceae and Staphylococcus aureus by using sparfloxacin.
引用
收藏
页码:2423 / 2427
页数:5
相关论文
共 26 条
[1]  
BENBROOK DM, 1986, ANTIMICROB AGENTS CH, V29, P1, DOI 10.1128/AAC.29.1.1
[2]   FLUOROMETRIC ASSAY FOR FLEROXACIN UPTAKE BY BACTERIAL-CELLS [J].
CHAPMAN, JS ;
GEORGOPAPADAKOU, NH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (01) :27-29
[3]   ANTISTAPHYLOCOCCAL ACTIVITIES OF SPARFLOXACIN (CI-978-AT-4140), OFLOXACIN, AND CIPROFLOXACIN [J].
CHAUDHRY, AZ ;
KNAPP, CC ;
SIERRAMADERO, J ;
WASHINGTON, JA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (09) :1843-1845
[4]   INVITRO ACTIVITY OF SPARFLOXACIN [J].
CHIN, NX ;
GU, JW ;
YU, KW ;
ZHANG, YX ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (03) :567-571
[5]   ASSOCIATION BETWEEN EARLY INHIBITION OF DNA-SYNTHESIS AND THE MICS AND MBCS OF CARBOXYQUINOLONE ANTIMICROBIAL AGENTS FOR WILD-TYPE AND MUTANT [GYRA NFXB(OMPF) ACRA] ESCHERICHIA-COLI K-12 [J].
CHOW, RT ;
DOUGHERTY, TJ ;
FRAIMOW, HS ;
BELLIN, FY ;
MILLER, MH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) :1113-1118
[6]   CROSS-RESISTANCE TO FLUOROQUINOLONES IN MULTIPLE-ANTIBIOTIC-RESISTANT (MAR) ESCHERICHIA-COLI SELECTED BY TETRACYCLINE OR CHLORAMPHENICOL - DECREASED DRUG ACCUMULATION ASSOCIATED WITH MEMBRANE-CHANGES IN ADDITION TO OMPF REDUCTION [J].
COHEN, SP ;
MCMURRY, LM ;
HOOPER, DC ;
WOLFSON, JS ;
LEVY, SB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1318-1325
[7]   INVITRO ACTIVITY OF SPARFLOXACIN, A NEW QUINOLONE ANTIMICROBIAL AGENT [J].
COOPER, MA ;
ANDREWS, JM ;
ASHBY, JP ;
MATTHEWS, RS ;
WISE, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 26 (05) :667-676
[8]   THE ACCUMULATION OF 5 QUINOLONE ANTIBACTERIAL AGENTS BY ESCHERICHIA-COLI [J].
DIVER, JM ;
PIDDOCK, LJV ;
WISE, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (03) :319-333
[9]   ISOLATION AND CHARACTERIZATION OF NORFLOXACIN-RESISTANT MUTANTS OF ESCHERICHIA-COLI K-12 [J].
HIRAI, K ;
AOYAMA, H ;
SUZUE, S ;
IRIKURA, T ;
IYOBE, S ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (02) :248-253
[10]   MECHANISMS OF QUINOLONE RESISTANCE IN ESCHERICHIA-COLI - CHARACTERIZATION OF NFXB AND CFXB, 2 MUTANT RESISTANCE LOCI DECREASING NORFLOXACIN ACCUMULATION [J].
HOOPER, DC ;
WOLFSON, JS ;
SOUZA, KS ;
NG, EY ;
MCHUGH, GL ;
SWARTZ, MN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (03) :283-290